» Articles » PMID: 8740040

Effects of Haloperidol in a Response-reinstatement Model of Heroin Relapse

Overview
Specialty Pharmacology
Date 1996 Apr 1
PMID 8740040
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The present study employed an animal model of drug relapse in which previously extinguished heroin self-administration behavior was reinstated following a single reinforced trial. Male albino rats were trained to traverse a straight-alley for a reinforcer consisting of a single IV injection of 0.06 mg/kg diacetylmorphine (heroin). Once the alley-running had been established, the heroin reinforcer was removed and the operant behavior permitted to extinguish over trials. On treatment day, animals were injected 45 min prior to testing with 0.0, 0.075, 0.10, 0.15 or 0.3 mg/kg of the dopamine receptor antagonist, haloperidol. A single trial was then conducted during which some animals continued to experience extinction conditions while others were injected with the heroin reinforcer upon entry into the goal box. The effects of these manipulations were determined during an additional single test trial conducted 24 h later when the subjects were no longer drugged. While heroin produced a reliable reinstatement in operant responding, this effect was dose-dependently prevented by pretreatment with haloperidol. These data suggest that dopamine receptor antagonism alters the reinforcing consequences of heroin administration as measured by heroin's ability to reinstate operant behavior following a prolonged period of nonreinforced responding.

Citing Articles

Low-dose polypharmacology targeting dopamine D1 and D3 receptors reduces cue-induced relapse to heroin seeking in rats.

Ewing S, Dorcely C, Maidi R, Paker G, Schelbaum E, Ranaldi R Addict Biol. 2021; 26(4):e12988.

PMID: 33496050 PMC: 8225548. DOI: 10.1111/adb.12988.


Novel Diels-Alder Type Adducts from Root Bark Targeting Human Monoamine Oxidase and Dopaminergic Receptors for the Management of Neurodegenerative Diseases.

Paudel P, Park S, Seong S, Jung H, Choi J Int J Mol Sci. 2019; 20(24).

PMID: 31835621 PMC: 6940761. DOI: 10.3390/ijms20246232.


Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.

Mantsch J, Baker D, Funk D, Le A, Shaham Y Neuropsychopharmacology. 2015; 41(1):335-56.

PMID: 25976297 PMC: 4677117. DOI: 10.1038/npp.2015.142.


The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research.

Bossert J, Marchant N, Calu D, Shaham Y Psychopharmacology (Berl). 2013; 229(3):453-76.

PMID: 23685858 PMC: 3770775. DOI: 10.1007/s00213-013-3120-y.


Roles of dopaminergic innervation of nucleus accumbens shell and dorsolateral caudate-putamen in cue-induced morphine seeking after prolonged abstinence and the underlying D1- and D2-like receptor mechanisms in rats.

Gao J, Li Y, Zhu N, Brimijoin S, Sui N J Psychopharmacol. 2012; 27(2):181-91.

PMID: 23151613 PMC: 3746592. DOI: 10.1177/0269881112466181.


References
1.
Jaffe J, Cascella N, Kumor K, Sherer M . Cocaine-induced cocaine craving. Psychopharmacology (Berl). 1989; 97(1):59-64. DOI: 10.1007/BF00443414. View

2.
Tobena A, Fernandez-Teruel A, Escorihuela R, Nunez J, Zapata A, Ferre P . Limits of habituation and extinction: implications for relapse prevention programs in addictions. Drug Alcohol Depend. 1993; 32(3):209-17. DOI: 10.1016/0376-8716(93)90085-5. View

3.
Bartus R . Short-term memory in the rhesus monkey: effects of dopamine blockade via acute haloperidol administration. Pharmacol Biochem Behav. 1978; 9(3):353-7. DOI: 10.1016/0091-3057(78)90296-4. View

4.
Bechara A, Martin G, Pridgar A, van der Kooy D . The parabrachial nucleus: a brain stem substrate critical for mediating the aversive motivational effects of morphine. Behav Neurosci. 1993; 107(1):147-60. DOI: 10.1037//0735-7044.107.1.147. View

5.
Shoaib M, Spanagel R . Mesolimbic sites mediate the discriminative stimulus effects of morphine. Eur J Pharmacol. 1994; 252(1):69-75. DOI: 10.1016/0014-2999(94)90576-2. View